Medicare Enrolled
Dr. Fauzia Paracha, MD
Hematology & Oncology · Newburgh, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Paracha from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Paracha?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Paracha
Dr. Fauzia Paracha is a hematology & oncology specialist in Newburgh, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Paracha performed 50,009 Medicare services across 1,385 unique beneficiaries.
Between the years covered by Open Payments, Dr. Paracha received a total of $14,950 from 60 pharmaceutical and/or device companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Paracha is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in NY
$14,950 industry payments
Medicare Practice Summary
Medicare Utilization ↗50,009
Medicare services
Top 13% in NY for hematology & oncology
1,385
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,632 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
35,501 | $0 | $1 |
| Anti-nausea injection (ondansetron/Zofran) | 5,271 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,498 | $8 | $10 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,301 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,122 | $8 | $26 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
951 | $1 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
940 | $25 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
901 | $102 | $275 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
568 | $11 | $70 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
359 | $55 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
358 | $75 | $202 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
342 | $113 | $300 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
244 | $1 | $10 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
138 | $48 | $104 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
134 | $67 | $150 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
129 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
107 | $24 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
69 | $110 | $225 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $153 | $332 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $116 | $281 |
| New patient office visit, complex (60-74 min) | 23 | $180 | $326 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.2% high complexity
86.2% medium
8.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,950
Total received (2018-2024)
Avg $2,136/year across 7 years
Top 20% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
632
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,930 (79.8%)
Other
Charitable contributions, space rental, and other categories
$1,819 (12.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,201 (8.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,108
2023
$2,678
2022
$2,544
2021
$2,696
2020
$2,497
2019
$1,263
2018
$1,164
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$280
Janssen Biotech, Inc.
$269
Merck Sharp & Dohme LLC
$168
BeiGene USA, Inc.
$140
PFIZER INC.
$131
Ipsen Biopharmaceuticals, Inc
$111
E.R. Squibb & Sons, L.L.C.
$106
AstraZeneca Pharmaceuticals LP
$100
ABBVIE INC.
$96
Lilly USA, LLC
$89
Celgene Corporation
$73
Gilead Sciences, Inc.
$46
Astellas Pharma US Inc
$45
Incyte Corporation
$41
Bayer Healthcare Pharmaceuticals Inc.
$38
Eisai Inc.
$37
PUMA BIOTECHNOLOGY, INC.
$33
ARRAY BIOPHARMA INC
$30
PROGENICS PHARMACEUTICALS, INC.
$28
Daiichi Sankyo Inc.
$27
EMD Serono, Inc.
$26
Genmab U.S., Inc.
$25
Regeneron Healthcare Solutions, Inc.
$25
Blueprint Medicines Corporation
$23
ADC Therapeutics America, Inc.
$22
PharmaEssentia USA Corporation
$22
GENZYME CORPORATION
$22
Takeda Pharmaceuticals U.S.A., Inc.
$21
Mirati Therapeutics, Inc.
$18
SOBI, INC
$17
Top 3 companies account for 34.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$4,015
Janssen Biotech, Inc.
$1,228
E.R. Squibb & Sons, L.L.C.
$980
PFIZER INC.
$934
AstraZeneca Pharmaceuticals LP
$651
Amgen Inc.
$599
Celgene Corporation
$561
Merck Sharp & Dohme LLC
$453
Incyte Corporation
$424
Merck Sharp & Dohme Corporation
$349
Genentech USA, Inc.
$339
Lilly USA, LLC
$281
NOVARTIS PHARMACEUTICALS CORPORATION
$250
Ipsen Biopharmaceuticals, Inc
$246
AbbVie Inc.
$230
EMD Serono, Inc.
$213
BeiGene USA, Inc.
$202
Exelixis Inc.
$186
GENZYME CORPORATION
$160
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
Taiho Oncology, Inc.
$144
Takeda Pharmaceuticals U.S.A., Inc.
$140
Puma Biotechnology, Inc.
$137
ARRAY BIOPHARMA INC
$130
Global Blood Therapeutics, Inc.
$130
Regeneron Healthcare Solutions, Inc.
$124
PUMA BIOTECHNOLOGY, INC.
$123
Janssen Pharmaceuticals, Inc
$121
Eisai Inc.
$114
ABBVIE INC.
$113
Alexion Pharmaceuticals, Inc.
$93
Gilead Sciences, Inc.
$91
Astellas Pharma US Inc
$85
Bayer Healthcare Pharmaceuticals Inc.
$82
Pharmacyclics LLC, An AbbVie Company
$73
Seagen Inc.
$68
Blueprint Medicines Corporation
$64
Daiichi Sankyo Inc.
$56
Mirati Therapeutics, Inc.
$52
MorphoSys, US Inc.
$48
PharmaEssentia USA Corporation
$46
GlaxoSmithKline, LLC.
$37
Acrotech Biopharma LLC
$37
Seattle Genetics, Inc.
$32
Bayer HealthCare Pharmaceuticals Inc.
$32
Myovant Sciences Inc.
$30
PROGENICS PHARMACEUTICALS, INC.
$28
AbbVie, Inc.
$27
Genmab U.S., Inc.
$25
Karyopharm Therapeutics Inc.
$25
JAZZ PHARMACEUTICALS INC.
$23
ADC Therapeutics America, Inc.
$22
Rigel Pharmaceuticals, Inc.
$22
Kite Pharma, Inc.
$21
AMAG Pharmaceuticals, Inc.
$18
SOBI, INC
$17
Blue Earth Diagnostics Limited
$17
EISAI INC.
$15
TG Therapeutics, Inc.
$15
Heron Therapeutics, Inc.
$9
Top 3 companies account for 41.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ADVATE · AFINITOR · AYVAKIT · Aranesp · Avastin · Axumin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CAMZYOS · CYRAMZA · Cabometyx · DARZALEX · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Erleada · FERAHEME · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · INQOVI · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · PYLARIFY · Perjeta · Pomalyst · REBLOZYL · RETEVMO · RYDAPT · Revlimid · SANDOSTATIN · SARCLISA · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · Tavalisse · Tazverik · Tivdak · Trodelvy · UKONIQ · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xtandi · Yescarta · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
34
Per 100K population
8.4
County median income
$96,497
Nearest hospital
MONTEFIORE ST LUKE'S CORNWALL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Paracha is a mixed practice specialist, with above-average Medicare volume (top 13% in NY), with low-engagement industry engagement in the top 20% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Paracha experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Paracha performed 35,501 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Paracha receive payments from pharmaceutical companies?
Yes. Dr. Paracha received a total of $14,950 from 60 companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Paracha's costs compare to other hematology & oncology specialists in Newburgh?
Dr. Paracha's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Paracha) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Newburgh
Browse hematology & oncology specialists in Newburgh ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology